Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Opioid analgesia in necrotizing pancreatitis: Incidence and timing of a hidden crisis.

American journal of surgery·2023

Same author

Operative treatment of portal vein aneurysm.

Surgery open science·2022

Same author

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts.

Regulatory toxicology and pharmacology : RTP·2022

Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022

Same author

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma.

The British journal of surgery·2021

Same author

Routine Gastric Decompression after Pancreatoduodenectomy: Treating the Surgeon?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2021

Same journal

Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

American journal of surgery·2026

Same journal

Does the risk outweigh the benefit? Clot progression, recanalization & complications of anticoagulation therapy in acute pancreatitis with concomitant splanchnic vein thrombosis.

American journal of surgery·2026

Same journal

High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

American journal of surgery·2026

Same journal

Women with firearm injuries: A multicenter mixed-methods study.

American journal of surgery·2026

Same journal

SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

American journal of surgery·2026

Same journal

Using Dr. Google and AI to stay informed.

American journal of surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

Smoking and IPMN malignant progression.

R A Carr¹, A M Roch¹, K Shaffer¹

¹Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.

American Journal of Surgery

|January 29, 2017

Summary

This summary is machine-generated.

Smoking does not directly worsen intraductal papillary mucinous neoplasm (IPMN) progression. However, smokers are diagnosed with invasive IPMN at a younger age, suggesting tobacco may accelerate disease development.

Keywords:

Age Intraductal papillary mucinous neoplasm (IPMN)Smoking

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Experiment Videos

Last Updated: Mar 8, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Area of Science:

Gastroenterology
Oncology
Pancreatic Diseases

Background:

Intraductal papillary mucinous neoplasm (IPMN) is a precursor to invasive pancreatic cancer.
Understanding risk factors for IPMN progression is crucial for early detection and management.

Purpose of the Study:

To investigate the association between smoking and the malignant progression of IPMN.
To determine if smoking influences the development of invasive pancreatic cancer from IPMN.

Main Methods:

Retrospective review of patients who underwent pancreatic resection for IPMN between 1991 and 2015.
Analysis of a prospectively collected database including 324 patients with complete data.

Main Results:

Smoking status did not significantly impact IPMN malignant progression (22% invasive grade in smokers vs. 18% in non-smokers).
Smokers were diagnosed with IPMN at a younger age (63 years) compared to non-smokers (68 years).
This age difference was also observed in the invasive IPMN subgroup.

Conclusions:

While smoking is not directly linked to IPMN malignant progression, it is associated with earlier diagnosis of invasive IPMN.
These findings suggest that tobacco exposure might accelerate the progression of IPMN to invasive cancer.